First Horizon Advisors’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$81.6K Buy
982
+65
+7% +$5.43K ﹤0.01% 784
2025
Q1
$76.9K Sell
917
-36
-4% -$3.35K ﹤0.01% 763
2024
Q4
$87.8K Sell
953
-81
-8% -$7.79K ﹤0.01% 734
2024
Q3
$96K Hold
1,034
﹤0.01% 737
2024
Q2
$85.1K Sell
1,034
-55
-5% -$4.04K ﹤0.01% 725
2024
Q1
$72.3K Hold
1,089
﹤0.01% 790
2023
Q4
$61.8K Buy
1,089
+41
+4% +$2.15K ﹤0.01% 832
2023
Q3
$57.1K Buy
1,048
+123
+13% +$7.29K ﹤0.01% 807
2023
Q2
$62.2K Sell
925
-41
-4% -$2.5K ﹤0.01% 795
2023
Q1
$49.7K Sell
966
-113
-10% -$5.49K ﹤0.01% 877
2022
Q4
$49.7K Sell
1,079
-252
-19% -$11.8K ﹤0.01% 858
2022
Q3
$67K Sell
1,331
-1,347
-50% -$67.3K ﹤0.01% 736
2022
Q2
$122K Buy
2,678
+2,559
+2,150% +$114K ﹤0.01% 597
2022
Q1
$6K Buy
+119
New +$5.33K ﹤0.01% 1248
2021
Q4
Sell
-51
Closed -$2K 2358
2021
Q3
$2K Hold
51
﹤0.01% 1989
2021
Q2
$3K Hold
51
﹤0.01% 1666
2021
Q1
$2K Buy
+51
New +$2.39K ﹤0.01% 1672

Other funds holding LMAT

First Horizon Advisors's LMAT Position: Q2 2025 in Review

First Horizon Advisors increased its LeMaitre Vascular (LMAT) stake by 7.1% in Q2 2025, buying an estimated $5.43K and bringing the position to 982 shares worth $81.6K. The position accounts for ﹤0.01% of the portfolio, ranked #784.

First Horizon Advisors first reported a position in LMAT in Q1 2021 and has held it in 17 quarters since. The position peaked at $122K in Q2 2022. 283 funds tracked by Wall St. Rank hold LMAT as of Q2 2025.

  • First Horizon Advisors held 982 shares of LeMaitre Vascular worth $81.6K as of Q2 2025.
  • First Horizon Advisors bought 65 LeMaitre Vascular shares in Q2 2025, an estimated $5.43K.
  • LeMaitre Vascular made up ﹤0.01% of First Horizon Advisors's portfolio in Q2 2025, its #784 holding.
  • First Horizon Advisors first reported a position in LeMaitre Vascular in Q1 2021 and has held it in 17 quarters since.
  • First Horizon Advisors's LeMaitre Vascular position peaked at $122K in Q2 2022.
  • 283 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2025.

Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.